Lisburn firm is market leader down under

From left to right ' Peter O'Halloran CIO and executive director, National Blood Authority; Dave Crockett, vice president sales and marketing, Cirdan-Ultra; Rebecca Heland, manager Blood Operations Centre, National Blood Authority; Dr Hugh Cormican, chief executive officer, Cirdan-Ultra; John McCaffrey, EMEA sales manager, Cirdan-Ultra.
From left to right ' Peter O'Halloran CIO and executive director, National Blood Authority; Dave Crockett, vice president sales and marketing, Cirdan-Ultra; Rebecca Heland, manager Blood Operations Centre, National Blood Authority; Dr Hugh Cormican, chief executive officer, Cirdan-Ultra; John McCaffrey, EMEA sales manager, Cirdan-Ultra.

A Lisburn company has signed a contract with the National Blood Authority (NBA) in Australia, a deal which makes it a market leader down under.

Cirdan is developing an internet interface with NBA’s existing BloodNet portal that enable medical laboratories across Australia to access its ULTRA Laboratory Information System (LIS) for blood testing operations.

The company’s ULTRA LIS system is already being used in hospital and clinical laboratories which process almost a quarter of Australia’s total blood supplies.

NBA is the Australian Government’s agency which manages and co-ordinates the supply of blood and blood products and other related services throughout the country. The contract means that laboratories already using Cirdan’s ULTRA LIS system will be able to access BloodNet.

Hugh Cormican, Cirdan ULTRA, chief executive, said: “The NBA contract for BloodNet will help reinforce our position as the market leader in Australia and lead to further business in this and other global markets.

“The NBA is a very impressive organisation and we are delighted to work with them to develop an interface to BloodNet. We plan to have the interface available in June to roll out to our customers so that they can realise the benefits in efficiency and patient care.

“The NBA approach is a tremendous endorsement of the functionality and efficiency of our ULTRA LIS technology. We have designed ULTRA to streamline workflow and diagnostic operations in clinical laboratories by enabling faster access to accurate and up-to-date patient information at local, regional and national levels. This means faster and more accurate data used in the treatment of patients ultimately leading to reduced waiting lists earlier treatment and improved outcomes.

Cirdan was established by Mr Cormican in 2010 and employs 20 people in the design and development of novel medical diagnostic equipment. It offers 24/7 support via its offices in Australia, Canada and the UK.

Laboratories with a BloodNet-LIS interface report significant time savings, with one major metropolitan laboratory in Sydney reporting a time saving for laboratory staff of 17.5 hours per week.